Flerie invests in life science companies globally, leveraging its operational experience, broad networks, and access to top biotech/pharma ecosystems. It focuses on accelerating portfolio companies through active ownership, supporting product development and commercialization to address unmet medical needs and improve health outcomes. The firm syndicates with investors worldwide to build scalable companies in drug development, biologics, and adjacent spaces.
Preferred startup development maturity for initial funding deployment.
Pioneering pharmaceutical and biotech projects with unmet medical needs, including immuno-oncology, metabolic diseases, and drug development
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
